An overview of hemoglobinopathies and the interpretation of newborn screening results

Pediatric Annals

Volumn 42, Issue 12, 2013, Pages 502-508

  Chandrakasan, Shanmuganathan ^a   Kamat, Deepak ^b  

^a Cincinnati Children's Hospital   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A2; HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN F;

ALPHA THALASSEMIA; BETA THALASSEMIA; DEVELOPMENT; ETHNICITY; FOLLOW UP; GENETIC TRAIT; GEOGRAPHIC DISTRIBUTION; HEMOGLOBINOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOELECTRIC FOCUSING; NEWBORN SCREENING; NOTE; PHENOTYPIC VARIATION; PREMATURITY; PREVALENCE; SICKLE CELL ANEMIA;

HEMOGLOBINOPATHIES; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 84890141624     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20131122-11     Document Type: Note

References (17)

1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(suppl 4):S512-S521.
2. Council of Regional Networks for Genetic Services. National Newborn Screening Report-1994. Atlanta, GA: The Council; 1999.
3. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986;314(25):1593-1599.
4. Consensus Conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA. 1987;258(9):1205-1209.
5. Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer. 2009;52(4):486-490.
6. Listernick R, Frisone L, Silverman BL. Delayed diagnosis of infants with abnormal neonatal screens. JAMA. 1992;267(8):1095-109.
7. Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states. Am J Med Genet C Semin Med Genet. 2008;148C(1):15-22.
8. Kemper AR, Uren RL, Moseley KL, Clark SJ. Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics. 2006;118(5):1836-1841.
9. Orkin SH, Nathan DG. Nathan and Oski's Hematology of Infancy and Childhood. 7th ed. Philadelphia: Saunders/Elsevier; 2009.
10. Centers for Disease Control and Prevention. Sickle cell disease. Data and Statistics. Available at: http://www.cdc.gov/ncbddd/sicklecell/data. html. Accessed Nov. 11, 2013.
11. The Management of Sickle Cell Disease. National Institutes of Health. Bethesda, MD: National Heart, Lung, and Blood Institute. Division of Blood Disease and Resources; 2002.
12. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol. 2000;63(4):205-211.
13. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317(13):781-787.
14. Pearson HA. Sickle cell trait and competitive athletics: is there a risk? Pediatrics. 1989;83(4):613-614.
15. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710-718.
16. Galacteros F, Kleman K, Caburi-Martin J, Beuzard Y, Rosa J, Lubin B. Cord blood screening for hemoglobin abnormalities by thin layer isoelectric focusing. Blood. 1980;5696):1068-1071.
17. van der Dijs FP, van den Berg GA, Schermer JG, Muskiet FD, Landman H, Muskiet FA. Screening cord blood for hemoglobinopathies and thalassemia by HPLC. Clin Chem. 1992;38(9):1864-1869.